TDOC,HIMS,LFMD,TOI,AIRS,SBC Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.12
Percentage change -1.33	%

Peers: AMWL DOCS CARA HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: VTI VB IWM VXF VBK IWN DFAT VTWO FNDA SCHA

Index	RUT	P/E	-	EPS (ttm)	-5.88	Insider Own	1.00%	Shs Outstand	173.41M	Perf Week	-1.66%
Market Cap	1.54B	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-3.46%	Shs Float	171.93M	Perf Month	-35.93%
Income	-1001.25M	PEG	-	EPS next Q	-0.34	Inst Own	73.81%	Short Float	14.55%	Perf Quarter	-19.27%
Sales	2.57B	P/S	0.60	EPS this Y	83.76%	Inst Trans	-0.17%	Short Ratio	3.37	Perf Half Y	23.50%
Book/sh	8.60	P/B	1.03	EPS next Y	8.81%	ROA	-23.65%	Short Interest	25.02M	Perf Year	-42.41%
Cash/sh	7.48	P/C	1.19	EPS next 5Y	48.98%	ROE	-52.46%	52W Range	6.76 - 15.68	Perf YTD	-2.31%
Dividend Est.	-	P/FCF	5.45	EPS past 5Y	-33.66%	ROI	-39.82%	52W High	-43.37%	Beta	1.67
Dividend TTM	-	Quick Ratio	1.69	Sales past 5Y	41.76%	Gross Margin	56.23%	52W Low	31.36%	ATR (14)	0.85
Dividend Ex-Date	-	Current Ratio	1.73	EPS Y/Y TTM	-338.56%	Oper. Margin	-8.13%	RSI (14)	36.08	Volatility	6.55% 8.73%
Employees	5500	Debt/Eq	1.06	Sales Y/Y TTM	-1.26%	Profit Margin	-38.97%	Recom	2.50	Target Price	10.60
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	-61.03%	Payout	-	Rel Volume	0.96	Prev Close	9.00
Sales Surprise	0.15%	EPS Surprise	-7.90%	Sales Q/Q	-3.03%	Earnings	Feb 26 AMC	Avg Volume	7.43M	Price	8.88
SMA20	-18.19%	SMA50	-15.38%	SMA200	-6.92%	Trades		Volume	7,141,521	Change	-1.33%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36
Jul-06-22	Reiterated	BofA Securities	Neutral	$36 → $42
May-05-22	Downgrade	Argus	Buy → Hold
Apr-28-22	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Today 09:00AM	Cylinder joins Teladoc Healths Connected Care Program to expand access to virtual digestive care (GlobeNewswire)
Mar-11-25 06:15PM	Teladoc (TDOC) Advances While Market Declines: Some Information for Investors (Zacks)
08:00AM	Teladoc Health Expands Connected Care Partnerships (GlobeNewswire)
05:04AM	Q4 Rundown: The RealReal (NASDAQ:REAL) Vs Other Online Marketplace Stocks (StockStory)
05:01AM	Q4 Online Marketplace Earnings: MercadoLibre (NASDAQ:MELI) Earns Top Marks (StockStory)
05:05AM	Loading…
Mar-10-25 05:05AM	Q4 Earnings Highs And Lows: EverQuote (NASDAQ:EVER) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Mar-07-25 08:02AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Mar-06-25 03:52PM	Teladoc stock jumps on GLP-1 deal with Eli Lilly (Yahoo Finance Video)
02:27PM	Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute (Yahoo Finance Video)
11:29AM	Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss (Benzinga)
08:31AM	Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care (GlobeNewswire)
Mar-05-25 06:00PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Mar-04-25 08:00AM	Teladoc Health Connects Digital & Community Providers to Deliver Next Generation of Virtually Integrated Care (GlobeNewswire)
Mar-03-25 06:15PM	Teladoc (TDOC) Stock Moves -1.36%: What You Should Know (Zacks)
Feb-28-25 10:27AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
04:29PM	Loading…
Feb-27-25 04:29PM	These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com) -13.56%
03:06PM	Why Teladoc (TDOC) Stock Is Trading Lower Today (StockStory)
02:57PM	Why Teladoc Stock Is Plummeting Today (Motley Fool)
12:59PM	Teladoc Health, Virgin Galactic: Trending Tickers (Yahoo Finance Video)
11:55AM	These Stocks Are Moving the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)
07:21AM	Q4 2024 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
06:44AM	Teladoc Health Shares Plunge 15% After-Hours as Q4 Loss Widens, Revenue Declines (GuruFocus.com)
06:02AM	Teladoc posts $1B loss in 2024 as BetterHelp lags (Healthcare Dive)
02:21AM	Teladoc Health Inc (TDOC) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-26-25 11:00PM	Teladoc Health (TDOC) Q4 2024 Earnings Call Transcript (Motley Fool)
06:30PM	Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings (Zacks)
06:15PM	Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:12PM	Teladoc: Q4 Earnings Snapshot (Associated Press Finance)
04:29PM	Teladocs (NYSE:TDOC) Q4 Earnings Results: Revenue In Line With Expectations But Stock Drops 11.7% (StockStory)
04:05PM	Teladoc Health Reports Full Year and Fourth Quarter 2024 Results (GlobeNewswire)
08:08AM	Loading…
Feb-25-25 08:08AM	Teladoc (TDOC) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-24-25 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Feb-21-25 09:15AM	What Analyst Projections for Key Metrics Reveal About Teladoc (TDOC) Q4 Earnings (Zacks) -9.30%
07:19AM	Why Teladoc Health, Inc. (TDOC) Crashed on Thursday (Insider Monkey)
Feb-20-25 12:05PM	Blue Orca short Teladoc, says far less profitable than believed (TipRanks) -7.84%
Feb-19-25 03:54PM	Why Teladoc Health (TDOC) Crashed on Tuesday? (Insider Monkey) +5.03%
02:46PM	Teladoc Health, Inc. (TDOC): the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey)
Feb-15-25 10:00AM	Is Teladoc Stock a Buy? (Motley Fool)
Feb-14-25 01:16PM	Teladoc Health, Inc. (TDOC): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey) +6.07%
04:02AM	Shutterstock (NYSE:SSTK): Strongest Q3 Results from the Online Marketplace Group (StockStory)
Feb-13-25 06:25AM	Citron Research Just Called This "Pandemic Relic" Stock a Hidden Artificial Intelligence (AI) Opportunity. Time to Buy? (Motley Fool) +7.65%
04:01AM	Unpacking Q3 Earnings: Cars.com (NYSE:CARS) In The Context Of Other Online Marketplace Stocks (StockStory)
Feb-09-25 02:52PM	Why Teladoc Health (TDOC) Soared Last Week? (Insider Monkey)
Feb-07-25 11:47AM	Teladoc (TDOC) Surges 8.8%: Is This an Indication of Further Gains? (Zacks) +8.19%
Feb-06-25 04:32PM	Why Teladoc Stock Surprisingly Popped Today (Motley Fool) +8.82%
04:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
01:07PM	Teladoc Health Stock Soars. Why Its An Under-the-Radar AI Play. (Barrons.com)
Feb-05-25 12:40PM	Teladoc Health to Acquire Catapult Health in $65 Million Deal to Expand Virtual Preventive Care (GuruFocus.com) +5.77%
07:00AM	Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy (GlobeNewswire)
05:43AM	Teladoc to acquire virtual care company Catapult Health for $65M (Healthcare Dive)
Feb-03-25 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
04:30PM	Teladoc Health to Announce Fourth Quarter 2024 Financial Results (GlobeNewswire)
Jan-29-25 09:39AM	Teladoc Health, Inc. (TDOC): Enhancing Virtual Healthcare with Generative AI (Insider Monkey)
08:04AM	Potential Revolution in Healthcare Brewing, Powered by AI Innovation (PR Newswire)
Jan-28-25 02:41PM	Teladoc Health, Inc. (TDOC): Is This Healthcare Stock A Good Buy? (Insider Monkey)
04:03AM	Q3 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Jan-27-25 06:15PM	Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-24-25 12:06PM	Teladoc Health Inc. (TDOC): GenAI Advancements Amid Bank of Americas Price Target Adjustment (Insider Monkey)
Jan-17-25 06:15PM	Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
05:58PM	Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 (PR Newswire)
06:05AM	Can Teladoc Stock Bounce Back in 2025? (Motley Fool)
Jan-16-25 08:45AM	How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection (GlobeNewswire)
Jan-15-25 05:04AM	Teladoc joins Amazons digital health benefits program (Healthcare Dive)
Jan-14-25 04:18PM	Amazon Expands Health Care Offerings Via Teladoc Partnership (Investor's Business Daily)
12:34PM	Teladoc Health Partners With Amazon to Expand Enrollment for Cardiometabolic Programs (GuruFocus.com)
06:35AM	Teladoc Health Soars 6.6% in Premarket on Game-Changing Amazon Partnership (GuruFocus.com)
Jan-13-25 07:00PM	Teladoc Health Joins Amazon's Health Benefits Connector for Cardiometabolic Programs (GlobeNewswire)
Jan-09-25 03:01PM	Why Teladoc Health Stock Crashed Again in 2024 (Motley Fool)
Jan-06-25 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Jan-04-25 11:42AM	Teladoc Health Inc (NYSE:TDOC): A Bullish Investment Perspective (Insider Monkey)
Jan-03-25 06:15PM	Teladoc (TDOC) Flat As Market Gains: What You Should Know (Zacks)
08:00AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
Dec-31-24 09:40AM	Should Value Investors Buy Teladoc Health (TDOC) Stock? (Zacks)
Dec-30-24 04:08AM	Teladoc (TDOC): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-27-24 06:15PM	Teladoc (TDOC) Stock Moves -0.84%: What You Should Know (Zacks)
Dec-18-24 07:55AM	Hedge Funds Think That Teladoc Health, Inc. (TDOC) Will Bounce Back Soon (Insider Monkey) -6.06%
Dec-16-24 06:45AM	Is Teladoc Health Stock a Buy? (Motley Fool)
Dec-15-24 09:00AM	Where Will Teladoc Health Be in 3 Years? (Motley Fool)
Dec-14-24 09:00PM	The Drugs Young Bankers Use to Get Through the Dayand Night (The Wall Street Journal)
Dec-12-24 11:23AM	AI Healthcare Innovations: How They're Shaping the Future for Patients and Investors (PR Newswire)
Dec-05-24 07:15PM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
06:55AM	Teladoc price target raised to $13 from $11 at Piper Sandler (TipRanks)
05:30AM	2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors (Motley Fool)
Nov-29-24 11:32AM	Teladoc (TDOC) Up 27% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-26-24 05:25AM	Teladoc Health introduces AI-powered Virtual Sitter (Hospital Management) -5.41%
Nov-25-24 08:30AM	Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution (GlobeNewswire) +13.18%
Nov-21-24 04:30PM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire) +15.56%
Nov-20-24 10:21AM	'The Shark Investor' Applies 'Shark Tank' Principles to Stock Picking (PR Newswire)
08:45AM	Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential (GlobeNewswire)
Nov-18-24 07:52AM	If You'd Invested $10,000 in Teladoc Stock 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
Nov-17-24 05:37AM	Where Will Teladoc Be in 5 Years? (Motley Fool)
Nov-13-24 06:05AM	Is Teladoc Health Stock a Buy? (Motley Fool)
Nov-07-24 04:30PM	Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08 (GlobeNewswire)
Nov-05-24 10:12AM	Every Teladoc Investor Should Keep an Eye on This Number (Motley Fool)
Oct-31-24 10:54AM	Q3 2024 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:16AM	Teladoc Health Inc (TDOC) Q3 2024 Earnings Call Highlights: Navigating Challenges and Strategic ... (GuruFocus.com)
12:00AM	Teladoc Health (TDOC) Q3 2024 Earnings Call Transcript (Motley Fool)
Oct-30-24 06:30PM	Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:23PM	Teladoc (NYSE:TDOC) Surprises With Q3 Sales, Stock Jumps 10.3% (StockStory)
05:30PM	Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rodrigues Fernando M.	President of BetterHelp	Mar 05 '25	Sale	9.20	3,558	32,734	0	Mar 06 04:04 PM
Rodrigues Fernando M.	Officer	Mar 05 '25	Proposed Sale	9.20	3,558	32,734		Mar 05 09:44 AM
Rodrigues Fernando M.	President of BetterHelp	Mar 03 '25	Sale	9.68	1,933	18,719	3,558	Mar 04 04:07 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	9.68	8,630	83,573	99,962	Mar 04 04:07 PM
Nueno Carlos	President, International	Mar 03 '25	Sale	9.68	2,347	22,728	2,932	Mar 04 04:06 PM
Bliss Kelly	President, U.S. Group Health	Mar 03 '25	Sale	9.68	2,904	28,122	35,421	Mar 04 04:06 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 03 '25	Sale	9.68	3,935	38,107	53,919	Mar 04 04:06 PM
Bliss Kelly	Officer	Mar 03 '25	Proposed Sale	9.68	2,904	28,124		Mar 03 04:29 PM
Murthy Mala	Officer	Mar 03 '25	Proposed Sale	9.68	8,630	83,576		Mar 03 04:22 PM
Nueno Carlos	Officer	Mar 03 '25	Proposed Sale	9.68	2,347	22,729		Mar 03 04:21 PM
Rodrigues Fernando M.	Officer	Mar 03 '25	Proposed Sale	9.68	1,933	18,720		Mar 03 04:20 PM
Vandervoort Adam C	Officer	Mar 03 '25	Proposed Sale	9.68	3,935	38,108		Mar 03 04:17 PM
Nanis Nikolaos P.	Officer	Jan 03 '25	Proposed Sale	9.33	502	4,681		Jan 03 05:31 PM
Waters Michael Willem	Officer	Dec 16 '24	Proposed Sale	10.28	4,652	47,823		Dec 16 10:46 AM
Nueno Carlos	President, International	Dec 03 '24	Sale	11.23	2,890	32,455	0	Dec 03 05:30 PM
Nueno Carlos	President, International	Dec 02 '24	Sale	11.93	2,389	28,494	2,890	Dec 03 05:30 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '24	Sale	11.93	4,004	47,756	50,050	Dec 03 05:29 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	11.93	8,783	104,755	92,788	Dec 03 05:28 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '24	Sale	11.07	14,091	156,001	0	Dec 03 05:26 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '24	Sale	11.93	7,873	93,901	14,091	Dec 03 05:26 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '24	Sale	11.93	2,040	24,331	32,244	Dec 03 05:20 PM
Rodrigues Fernando M.	Officer	Dec 03 '24	Proposed Sale	11.07	14,091	156,002		Dec 03 12:11 PM
Nueno Carlos	Officer	Dec 03 '24	Proposed Sale	11.23	2,890	32,455		Dec 03 11:02 AM
Raman-Tangella Vidya	Officer	Dec 03 '24	Proposed Sale	11.23	468	5,256		Dec 03 09:56 AM
Murthy Mala	Officer	Dec 02 '24	Proposed Sale	11.93	8,783	104,752		Dec 02 04:53 PM
Raman-Tangella Vidya	Officer	Dec 02 '24	Proposed Sale	11.93	1,588	18,940		Dec 02 04:49 PM
Vandervoort Adam C	Officer	Dec 02 '24	Proposed Sale	11.93	4,004	47,754		Dec 02 04:45 PM
Waters Michael Willem	Officer	Dec 02 '24	Proposed Sale	11.93	4,234	50,498		Dec 02 04:41 PM
Nanis Nikolaos P.	Officer	Dec 02 '24	Proposed Sale	11.93	4,218	50,307		Dec 02 04:11 PM
Bliss Kelly	Officer	Dec 02 '24	Proposed Sale	11.93	2,040	24,330		Dec 02 04:08 PM
Nueno Carlos	Officer	Dec 02 '24	Proposed Sale	11.93	2,389	28,493		Dec 02 04:04 PM
Rodrigues Fernando M.	Officer	Dec 02 '24	Proposed Sale	11.93	7,873	93,899		Dec 02 03:25 PM
Verstraete Stephany	Former Officer	Nov 19 '24	Proposed Sale	8.92	75,463	673,130		Nov 19 11:25 AM
Geshuri Arnnon	Former Officer	Nov 15 '24	Proposed Sale	9.21	34,456	317,512		Nov 15 03:32 PM
Geshuri Arnnon	Former Officer	Nov 12 '24	Proposed Sale	9.58	60,000	574,800		Nov 12 02:20 PM
Raman-Tangella Vidya	Officer	Nov 05 '24	Proposed Sale	8.88	1,537	13,649		Nov 05 10:08 AM
Waters Michael Willem	Officer	Nov 04 '24	Proposed Sale	8.67	6,097	52,845		Nov 04 04:50 PM
Geshuri Arnnon	Former Officer	Nov 04 '24	Proposed Sale	8.87	160,278	1,421,691		Nov 04 04:21 PM
Raman-Tangella Vidya	Officer	Nov 04 '24	Proposed Sale	8.67	4,776	41,395		Nov 04 03:55 PM
Verstraete Stephany	Former Officer	Oct 31 '24	Proposed Sale	9.23	16,992	156,755		Oct 31 03:13 PM
Trencher Daniel	Former Officer	Oct 29 '24	Proposed Sale	9.15	18,000	164,739		Oct 29 01:17 PM
Turitz Andrew	Former Officer	Oct 11 '24	Proposed Sale	9.49	38,983	370,102		Oct 11 03:27 PM
Kornwasser Laizer	Former Officer	Oct 09 '24	Proposed Sale	8.90	29,516	262,825		Oct 09 03:16 PM
Trencher Daniel	Former Officer	Oct 08 '24	Proposed Sale	8.58	8,343	71,612		Oct 08 03:22 PM
Turitz Andrew	Former Officer	Oct 08 '24	Proposed Sale	8.58	7,398	63,501		Oct 08 03:21 PM
Bliss Kelly	President, U.S. Group Health	Oct 02 '24	Sale	8.68	897	7,783	28,203	Oct 02 04:13 PM
Nanis Nikolaos P.	Officer	Oct 02 '24	Proposed Sale	8.68	454	3,939		Oct 02 03:20 PM
Bliss Kelly	Officer	Oct 02 '24	Proposed Sale	8.68	897	7,783		Oct 02 03:19 PM
Raman-Tangella Vidya	Officer	Oct 02 '24	Proposed Sale	8.73	14,737	128,654		Oct 02 10:22 AM
Trencher Daniel	Former Officer	Sep 16 '24	Proposed Sale	8.21	9,960	81,773		Sep 16 03:35 PM
MCKINLEY THOMAS	Director	Sep 12 '24	Buy	7.69	4,000	30,756	39,077	Sep 13 05:14 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 04 '24	Sale	7.26	20,773	150,812	20,773	Sep 05 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 04 '24	Sale	7.26	468	3,398	33,665	Sep 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Sep 03 '24	Sale	7.16	1,795	12,859	44,914	Sep 04 04:13 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 03 '24	Sale	7.16	8,750	62,685	85,767	Sep 04 04:13 PM
Nanis Nikolaos P.	Chief Technology Officer	Sep 03 '24	Sale	7.16	1,033	7,400	75,410	Sep 04 04:12 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 03 '24	Sale	7.16	2,817	20,181	46,250	Sep 04 04:12 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Sep 03 '24	Sale	7.16	2,083	14,923	48,843	Sep 04 04:12 PM
Cave James L.	INTERIM CAO	Sep 03 '24	Sale	7.16	555	3,976	13,808	Sep 04 04:12 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Sep 03 '24	Sale	7.16	1,777	12,730	31,465	Sep 04 04:12 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Sep 03 '24	Sale	7.16	4,218	30,218	78,309	Sep 04 04:11 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 03 '24	Sale	7.16	1,617	11,584	41,546	Sep 04 04:11 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	7.16	1,114	7,981	34,133	Sep 04 04:11 PM
Raman-Tangella Vidya	Officer	Sep 04 '24	Proposed Sale	7.26	468	3,398		Sep 04 10:25 AM
Turitz Andrew	Officer	Sep 04 '24	Proposed Sale	7.26	20,773	150,812		Sep 04 10:18 AM
Geshuri Arnnon	Officer	Sep 03 '24	Proposed Sale	7.16	1,795	12,859		Sep 03 04:06 PM
Nanis Nikolaos P.	Officer	Sep 03 '24	Proposed Sale	7.16	1,033	7,400		Sep 03 03:54 PM
Murthy Mala	Officer	Sep 03 '24	Proposed Sale	7.16	8,750	62,681		Sep 03 03:49 PM
Verstraete Stephany	Officer	Sep 03 '24	Proposed Sale	7.16	2,083	14,922		Sep 03 03:41 PM
Waters Michael Willem	Officer	Sep 03 '24	Proposed Sale	7.16	4,218	30,216		Sep 03 03:35 PM
Vandervoort Adam C	Officer	Sep 03 '24	Proposed Sale	7.16	2,817	20,180		Sep 03 03:32 PM
Raman-Tangella Vidya	Officer	Sep 03 '24	Proposed Sale	7.16	1,114	7,980		Sep 03 03:27 PM
Trencher Daniel	Officer	Sep 03 '24	Proposed Sale	7.16	1,777	12,730		Sep 03 03:13 PM
Turitz Andrew	Officer	Sep 03 '24	Proposed Sale	7.17	1,617	11,587		Sep 03 03:09 PM
Smith Mark Douglas	Director	Aug 15 '24	Buy	7.08	4,000	28,312	8,355	Aug 19 04:10 PM
Nanis Nikolaos P.	Chief Technology Officer	Aug 12 '24	Sale	7.13	206	1,470	73,588	Aug 13 04:16 PM
Nanis Nikolaos P.	Officer	Aug 12 '24	Proposed Sale	7.14	206	1,470		Aug 12 03:28 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Aug 07 '24	Sale	7.60	15,000	114,000	45,158	Aug 08 05:51 PM
MCKINLEY THOMAS	Director	Aug 06 '24	Buy	7.57	7,000	52,990	31,077	Aug 08 05:49 PM
MCKINLEY THOMAS	Director	Aug 07 '24	Buy	7.19	4,000	28,756	35,077	Aug 08 05:49 PM
Verstraete Stephany	Officer	Aug 07 '24	Proposed Sale	7.60	15,000	114,000		Aug 07 12:14 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Aug 05 '24	Sale	7.33	1,537	11,266	32,130	Aug 06 06:10 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Aug 02 '24	Sale	8.14	6,053	49,284	74,214	Aug 05 05:01 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Aug 02 '24	Sale	8.14	3,857	31,404	33,667	Aug 05 04:59 PM
Kornwasser Laizer	Advisor to the CEO	Aug 02 '24	Sale	8.14	10,879	88,577	99,929	Aug 05 04:56 PM
Raman-Tangella Vidya	Officer	Aug 05 '24	Proposed Sale	7.33	1,537	11,266		Aug 05 11:11 AM
Waters Michael Willem	Officer	Aug 02 '24	Proposed Sale	8.14	6,053	49,285		Aug 02 03:27 PM
Raman-Tangella Vidya	Officer	Aug 02 '24	Proposed Sale	8.14	3,857	31,404		Aug 02 03:22 PM
Kornwasser Laizer	Officer	Aug 02 '24	Proposed Sale	8.14	10,879	88,579		Aug 02 03:18 PM
Nanis Nikolaos P.	Chief Technology Officer	Jul 02 '24	Sale	9.39	442	4,150	73,226	Jul 02 05:00 PM
Murthy Mala	ACTING CEO, CFO	Jun 03 '24	Sale	11.16	8,807	98,260	78,713	Jun 04 04:07 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Jun 03 '24	Sale	11.16	1,807	20,161	41,686	Jun 04 04:07 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Jun 03 '24	Sale	11.16	1,627	18,152	37,659	Jun 04 04:06 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Jun 03 '24	Sale	11.16	4,246	47,373	68,948	Jun 04 04:06 PM
Kornwasser Laizer	PRESIDENT, ENTERPRISE GROWTH	Jun 03 '24	Sale	11.16	4,812	53,687	90,610	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	May 31 '24	Sale	11.21	3,407	38,192	28,870	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Jun 03 '24	Sale	11.16	1,122	12,518	27,748	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Jun 04 '24	Sale	11.04	468	5,167	27,280	Jun 04 04:06 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Jun 03 '24	Sale	11.16	1,790	19,971	28,322	Jun 04 04:06 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Jun 03 '24	Sale	11.16	2,096	23,385	60,158	Jun 04 04:05 PM

Dollar change -0.78
Percentage change -2.25	%

HIMS Hims & Hers Health Inc daily Stock Chart

Peers: CVS WBA TDOC AMZN JNJ UNH HUM CI PFE GDRX

| Held by: IJR VTI IWM VB VXF VBK IJT SPSM IWO SLYG

Index	RUT	P/E	63.44	EPS (ttm)	0.53	Insider Own	18.31%	Shs Outstand	212.46M	Perf Week	-17.02%
Market Cap	7.54B	Forward P/E	39.45	EPS next Y	0.86	Insider Trans	-6.90%	Shs Float	181.48M	Perf Month	-24.21%
Income	126.04M	PEG	2.04	EPS next Q	0.11	Inst Own	73.74%	Short Float	28.57%	Perf Quarter	-0.88%
Sales	1.48B	P/S	5.11	EPS this Y	12.05%	Inst Trans	19.29%	Short Ratio	2.53	Perf Half Y	142.88%
Book/sh	2.16	P/B	15.72	EPS next Y	44.82%	ROA	21.62%	Short Interest	51.84M	Perf Year	137.94%
Cash/sh	1.35	P/C	25.11	EPS next 5Y	31.05%	ROE	30.71%	52W Range	11.20 - 72.98	Perf YTD	40.32%
Dividend Est.	-	P/FCF	38.01	EPS past 5Y	17.22%	ROI	25.92%	52W High	-53.51%	Beta	1.60
Dividend TTM	-	Quick Ratio	1.50	Sales past 5Y	62.28%	Gross Margin	70.39%	52W Low	202.95%	ATR (14)	5.63
Dividend Ex-Date	-	Current Ratio	1.79	EPS Y/Y TTM	614.50%	Oper. Margin	4.61%	RSI (14)	40.94	Volatility	11.98% 13.99%
Employees	1637	Debt/Eq	0.02	Sales Y/Y TTM	69.33%	Profit Margin	8.54%	Recom	2.47	Target Price	45.81
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	1830.36%	Payout	0.00%	Rel Volume	1.01	Prev Close	34.71
Sales Surprise	2.18%	EPS Surprise	1.57%	Sales Q/Q	95.09%	Earnings	Feb 24 AMC	Avg Volume	20.47M	Price	33.93
SMA20	-26.55%	SMA50	-9.47%	SMA200	34.06%	Trades		Volume	20,695,386	Change	-2.25%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral	$8 → $6
Sep-07-22	Initiated	Truist	Hold	$7

Show Previous Ratings

Mar-11-25 05:30AM	Define Ventures Appoints Carolyn Magill as Venture Partner (PR Newswire)
Mar-07-25 06:19PM	DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
02:52PM	Why Hims & Hers Health, Inc. (HIMS) Crashed on Thursday (Insider Monkey)
Mar-06-25 05:33PM	Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private (Yahoo Finance) -15.90%
05:33PM	Walgreens announces up to $27.3B deal with Sycamore Partners (Yahoo Finance)
05:33PM	Loading…
05:33PM	Walgreens announces a $10 billion deal with Sycamore Partners to take the drugstore chain private (Yahoo Finance)
Mar-05-25 04:17PM	Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
11:51AM	Hims & Hers Hammered After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
09:51AM	Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health (Investor's Business Daily)
Feb-28-25 11:49AM	Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up (Investor's Business Daily) +9.07%
Feb-25-25 04:19PM	Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings (Investor's Business Daily) -22.32% +5.09%
03:32PM	Stock Market Today: Dow Jones Improves; Tesla Skids Again While Techs Keep Tumbling (Live Coverage) (Investor's Business Daily)
11:52AM	Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs (Yahoo Finance)
11:21AM	Home Depot, Hims & Hers, bitcoin and crypto stocks: Market Minute (Yahoo Finance Video)
11:07AM	Stock Market Today: Dow Jones, S&P 500 Fall; Hims & Hers Tanks, Bitcoin Falls (Live Coverage) (Investor's Business Daily)
09:53AM	Loading…
09:53AM	Hims & Hers stock collapses, may halt some weight-loss drug sales (Yahoo Finance Video)
Feb-24-25 06:21PM	Hims & Hers to 'treat multiple specialties,' not just weight loss (Yahoo Finance Video)
04:26PM	Hims & Hers stock tumbles despite beating Q4 revenue estimates (Yahoo Finance Video)
04:17PM	IBD 50's No. 2, Hims & Hers, Crashes 15% Despite Upbeat Earnings (Investor's Business Daily)
04:05PM	Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
12:57PM	What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle (Investor's Business Daily)
Feb-22-25 07:31PM	Why Hims & Hers Health, Inc. (HIMS) Crashed on Friday (Insider Monkey)
Feb-21-25 04:33PM	Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage (Investor's Business Daily) -25.79%
04:16PM	Hims & Hers shares dive on end of weight loss drug shortage (Yahoo Finance Video)
12:39PM	CrowdStrike, Hims & Hers, Rivian: Market Minute (Yahoo Finance Video)
09:00AM	Hims & Hers Acquires US-based Peptide Facility (Business Wire)
Feb-20-25 12:00PM	Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz (TipRanks)
Feb-19-25 05:23PM	'Health insurance companies are always going to need a PBM': CVS president Prem Shah (Yahoo Finance) +17.50%
04:12PM	Hims & Hers Health surges on acquisition for at-home testing (Yahoo Finance Video)
03:24PM	Short sellers lose $73 billion amid market rally to start 2025 (Yahoo Finance)
09:00AM	Loading…
09:00AM	Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers (Business Wire)
Feb-13-25 03:52PM	Senate confirms RFK Jr. as Trump's health secretary (Yahoo Finance Video) +27.71%
03:32PM	Hims & Hers stock sees another spike in trading days after Super Bowl ad (Yahoo Finance)
Feb-12-25 08:23AM	Hims & Hers Option Trade Offers $410 Return Or 17% Discount (Investor's Business Daily) +6.33%
Feb-10-25 04:27PM	Stock Market Today: Nvidia Helps Boost Dow Jones Higher; Meta Keeps Rally Alive (Live Coverage) (Investor's Business Daily) +5.22%
02:58PM	Stock Market Today: Nvidia A Big Gainer On Dow Jones; Uber Looks To Keep Rally Going (Live Coverage) (Investor's Business Daily)
01:33PM	Stock Market Today: Dow Jones Gets Help From Nvidia; Palantir Back Near A High (Live Coverage) (Investor's Business Daily)
12:20PM	Super Bowl: AI ads just 'fell flat' during the big game (Yahoo Finance Video)
10:34AM	Hims & Hers Super Bowl ad stirs up controversy with lawmakers (Yahoo Finance Video)
07:00AM	Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business (The Wall Street Journal)
Feb-07-25 04:42PM	IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad (Investor's Business Daily) +5.14%
06:00AM	Super Bowl Ads Will Be High on AI, Low on Politics (The Wall Street Journal)
Feb-04-25 09:00AM	Hims & Hers Launches Health Collective and Community Member Council (Business Wire) +7.50%
Feb-03-25 04:05PM	Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 (Business Wire)
12:17PM	Hims & Hers Health Inc. (HIMS): Among The Stocks That Started The Year On A High (Insider Monkey)
Feb-02-25 04:37PM	Why Hims & Hers Health (HIMS) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Feb-01-25 05:29PM	Why Hims & Hers Health (HIMS) Skyrocketed on Friday? (Insider Monkey)
Jan-28-25 06:00AM	Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl (The Wall Street Journal)
Jan-26-25 02:00AM	Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now (Insider Monkey)
Dec-19-24 04:18PM	IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List (Investor's Business Daily) -7.67%
04:03PM	Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls (Yahoo Finance Video)
03:57PM	FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next (Yahoo Finance)
Dec-17-24 10:48AM	Tesla, crypto miners, Hims & Hers Health: Trending Tickers (Yahoo Finance Video)
Dec-12-24 09:00AM	The Shape of America 2024: Hims and Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
09:00AM	The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
Dec-05-24 08:00AM	The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market (Investor's Business Daily) -6.84%
Dec-03-24 12:58PM	Hims and Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
12:58PM	Hims & Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
Nov-25-24 04:14PM	Hims & Hers surges: Analysts say it's well-positioned under Trump (Yahoo Finance Video) +23.77%
Nov-21-24 12:00PM	Hims and Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire) +10.83%
12:00PM	Hims & Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily) -7.39%
Nov-18-24 06:00AM	Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions (Business Wire) +8.64%
Nov-17-24 04:53PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
Nov-15-24 11:25AM	Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally (Investor's Business Daily) -7.34%
Nov-14-24 05:04PM	Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments (The Wall Street Journal) -24.46%
02:02PM	Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage) (Investor's Business Daily)
Nov-13-24 09:48AM	Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision (Yahoo Finance)
09:48AM	Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA (Yahoo Finance)
09:15AM	Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue (Business Wire)
Nov-05-24 04:11PM	Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025 (Investopedia) +13.47%
04:07PM	IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory (Investor's Business Daily)
12:29PM	Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories (Yahoo Finance Video)
11:32AM	Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims (The Wall Street Journal)
Nov-04-24 07:00PM	Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences. (Yahoo Finance Video)
04:05PM	Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:00AM	How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals (Business Wire)
Oct-27-24 11:47AM	Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage (Yahoo Finance)
Oct-22-24 09:00AM	Define Ventures Appoints Bruce Broussard as Venture Partner (PR Newswire)
Oct-21-24 01:43PM	Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug (Investor's Business Daily)
09:00AM	Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers (Business Wire)
Oct-19-24 03:20PM	FDA not planning to take action against GLP-1 compounders, Endpoints says (TipRanks)
Oct-16-24 04:19PM	Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk. (Investor's Business Daily)
08:00AM	Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk. (Investor's Business Daily)
Oct-15-24 01:04PM	Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation (Yahoo Finance) +11.22%
Oct-14-24 04:25PM	Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs (Investopedia) +9.68%
04:06PM	Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug (Investor's Business Daily)
04:05PM	Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024 (Business Wire)
03:40PM	Hims & Hers surges as FDA mulls over compounded drugs limit (Yahoo Finance Video)
Oct-10-24 04:39PM	WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model' (Yahoo Finance)
04:39PM	WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.' (Yahoo Finance)
04:39PM	WeightWatchers rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.' (Yahoo Finance)
Oct-04-24 06:05PM	Hims & Hers Health Set to Join S&P SmallCap 600 (PR Newswire) +10.08%
12:04PM	Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list (Yahoo Finance Video)
Oct-03-24 03:07PM	For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away (The Wall Street Journal) -9.60%
02:50PM	Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia (The Wall Street Journal)
01:39PM	Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List (Investopedia)
11:10AM	Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list (Yahoo Finance Video)
Sep-18-24 09:00AM	Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders (Business Wire)
Sep-06-24 04:52PM	Why Big Pharma is betting on telehealth strategies (Yahoo Finance) -5.41%

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM
Chi Michael	Officer	Feb 24 '25	Proposed Sale	48.14	17,303	832,966		Feb 24 10:46 AM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Option Exercise	2.43	125,335	304,564	223,022	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.27	128,127	7,466,121	97,687	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.15	47,534	2,763,942	427,796	Feb 20 08:18 PM
Boughton Soleil	Chief Legal Officer	Feb 18 '25	Sale	60.69	4,152	251,985	157,345	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Option Exercise	13.90	7,500	104,250	201,101	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Sale	59.26	7,500	444,450	193,601	Feb 20 08:17 PM
Chi Michael	Officer	Feb 19 '25	Proposed Sale	59.26	7,500	444,450		Feb 19 10:16 AM
Boughton Soleil	Officer	Feb 18 '25	Proposed Sale	60.69	4,152	251,985		Feb 18 11:22 AM
Dudum Andrew	Officer	Feb 18 '25	Proposed Sale	58.24	175,661	10,230,058		Feb 18 11:10 AM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Option Exercise	0.40	67,687	27,075	774,559	Feb 14 04:49 PM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Sale	44.71	67,687	3,026,624	706,872	Feb 14 04:49 PM
Melissa Baird	Officer	Feb 12 '25	Proposed Sale	46.34	67,687	3,136,616		Feb 12 04:36 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Feb 11 04:16 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Sale	43.28	7,259	314,170	193,601	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Option Exercise	5.01	6,437	32,249	119,370	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Sale	43.01	11,581	498,100	107,789	Feb 11 04:16 PM
Chi Michael	Officer	Feb 10 '25	Proposed Sale	43.28	7,259	314,170		Feb 10 12:09 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Option Exercise	5.01	6,437	32,249	124,514	Feb 05 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Sale	38.92	11,581	450,730	112,933	Feb 05 04:31 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Option Exercise	2.43	100,000	243,000	127,918	Feb 04 04:26 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Sale	35.22	100,000	3,522,300	27,918	Feb 04 04:26 PM
Boughton Soleil	Chief Legal Officer	Feb 03 '25	Sale	35.30	4,153	146,601	161,497	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Option Exercise	11.53	2,054	23,683	195,655	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Sale	35.30	2,054	72,506	193,601	Feb 04 04:25 PM
Boughton Soleil	Officer	Feb 03 '25	Proposed Sale	35.30	4,153	146,601		Feb 03 11:11 AM
Chi Michael	Officer	Feb 03 '25	Proposed Sale	35.30	2,054	72,506		Feb 03 11:11 AM
Dudum Andrew	Officer	Jan 31 '25	Proposed Sale	35.22	100,000	3,522,297		Jan 31 10:43 AM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Option Exercise	5.01	17,304	86,693	210,905	Jan 24 05:20 PM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Sale	31.00	17,304	536,424	193,601	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Option Exercise	2.43	27,098	65,848	55,016	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Sale	30.08	27,098	815,029	27,918	Jan 24 05:20 PM
Chi Michael	Officer	Jan 24 '25	Proposed Sale	31.00	17,304	536,424		Jan 24 09:53 AM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Option Exercise	5.01	50,000	250,500	219,803	Jan 23 04:32 PM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Sale	29.90	54,153	1,619,108	165,650	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Option Exercise	0.40	67,687	27,075	774,559	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Sale	29.35	67,687	1,986,731	706,872	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Option Exercise	13.90	306	4,253	193,907	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Sale	28.68	306	8,776	193,601	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Option Exercise	2.43	14,269	34,674	42,187	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Option Exercise	2.43	300	729	28,218	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Sale	30.08	14,269	429,184	27,918	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Sale	30.00	300	9,000	27,918	Jan 23 04:32 PM
Dudum Andrew	Officer	Jan 23 '25	Proposed Sale	30.08	27,098	815,030		Jan 23 12:55 PM
Dudum Andrew	Officer	Jan 22 '25	Proposed Sale	30.08	14,269	429,184		Jan 22 04:24 PM
Melissa Baird	Officer	Jan 21 '25	Proposed Sale	29.81	67,687	2,017,749		Jan 21 04:55 PM
Dudum Andrew	Officer	Jan 21 '25	Proposed Sale	30.00	300	9,000		Jan 21 04:54 PM
Boughton Soleil	Officer	Jan 21 '25	Proposed Sale	29.90	54,153	1,619,108		Jan 21 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Option Exercise	2.43	33,668	81,813	64,378	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.01	47,534	1,283,884	475,330	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.09	36,460	987,529	27,918	Jan 21 04:13 PM
Chi Michael	Officer	Jan 21 '25	Proposed Sale	28.68	306	8,776		Jan 21 10:16 AM
Dudum Andrew	Officer	Jan 16 '25	Proposed Sale	27.04	83,994	2,271,414		Jan 16 12:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Option Exercise	5.01	6,437	32,249	129,658	Jan 14 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Sale	24.44	11,581	283,083	118,077	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Sale	24.07	7,259	174,724	193,601	Jan 14 04:31 PM
Chi Michael	Officer	Jan 10 '25	Proposed Sale	24.07	7,259	174,724		Jan 10 10:39 AM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Option Exercise	3.85	254,023	979,134	438,735	Jan 07 04:48 PM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Sale	27.75	268,932	7,463,195	169,803	Jan 07 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Option Exercise	5.01	6,437	32,249	134,802	Jan 06 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Sale	24.68	11,581	285,784	123,221	Jan 06 04:40 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Option Exercise	11.53	2,055	23,694	195,656	Jan 06 04:39 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Sale	24.62	2,055	50,594	193,601	Jan 06 04:39 PM
Boughton Soleil	Officer	Jan 06 '25	Proposed Sale	27.75	268,932	7,463,195		Jan 06 01:05 PM
Chi Michael	Officer	Jan 02 '25	Proposed Sale	24.62	2,055	50,594		Jan 02 10:51 AM
Baird Melissa	Chief Operating Officer	Dec 27 '24	Option Exercise	4.56	31,518	143,669	706,872	Dec 30 04:22 PM
Okupe Oluyemi	Chief Financial Officer	Dec 26 '24	Sale	29.98	4,213	126,318	128,365	Dec 27 04:48 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Option Exercise	5.01	17,303	86,688	210,904	Dec 27 04:47 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Sale	27.97	17,303	483,965	193,601	Dec 27 04:47 PM
Chi Michael	Officer	Dec 24 '24	Proposed Sale	27.97	17,303	483,965		Dec 26 08:51 AM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Option Exercise	13.90	7,500	104,250	201,101	Dec 23 04:40 PM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Sale	26.00	7,500	195,000	193,601	Dec 23 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Dec 20 '24	Sale	25.77	18,959	488,531	132,578	Dec 23 04:40 PM
Oluyemi Okupe	Officer	Dec 20 '24	Proposed Sale	26.20	69,496	1,820,795		Dec 20 04:34 PM
Chi Michael	Officer	Dec 19 '24	Proposed Sale	26.00	7,500	195,000		Dec 19 10:13 AM
Chi Michael	Chief Commercial Officer	Dec 17 '24	Sale	32.20	25,550	822,710	193,601	Dec 17 07:03 PM
Becklund Irene	PAO	Dec 16 '24	Option Exercise	9.41	472	4,442	17,803	Dec 17 07:02 PM
Becklund Irene	PAO	Dec 17 '24	Sale	32.20	10,012	322,386	7,319	Dec 17 07:02 PM
Becklund Irene	PAO	Dec 16 '24	Sale	29.58	472	13,962	17,331	Dec 17 07:02 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Option Exercise	2.43	75,335	183,064	151,623	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 17 '24	Sale	32.09	79,246	2,543,119	30,710	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Sale	29.62	78,127	2,314,196	109,956	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Sale	29.18	47,534	1,386,968	522,864	Dec 17 07:01 PM
Dudum Andrew	Officer	Dec 17 '24	Proposed Sale	32.09	79,246	2,543,119		Dec 17 01:54 PM
Becklund Irene	Officer	Dec 17 '24	Proposed Sale	32.20	10,012	322,386		Dec 17 10:52 AM
Chi Michael	Officer	Dec 17 '24	Proposed Sale	32.20	25,550	822,710		Dec 17 10:13 AM
Dudum Andrew	Officer	Dec 16 '24	Proposed Sale	29.45	125,661	3,701,163		Dec 16 02:19 PM
Becklund Irene	Officer	Dec 16 '24	Proposed Sale	29.58	472	13,962		Dec 16 11:00 AM
Chi Michael	Chief Commercial Officer	Dec 10 '24	Option Exercise	6.82	7,259	49,506	192,206	Dec 12 05:02 PM
Chi Michael	Chief Commercial Officer	Dec 10 '24	Sale	32.25	7,259	234,103	184,947	Dec 12 05:02 PM
Baird Melissa	Chief Operating Officer	Dec 10 '24	Option Exercise	0.40	85,561	34,224	716,547	Dec 12 05:02 PM
Baird Melissa	Chief Operating Officer	Dec 10 '24	Sale	31.01	85,561	2,653,129	630,986	Dec 12 05:02 PM

Dollar change +0.20
Percentage change 3.50	%

Peers: HIMS CVS TDOC AMWL DOCS LFST SEM AMED EHC CHE

| Held by: IWM VTI VXF IWO VTWO IWN IWC JPSE ITOT GSSC

Index	RUT	P/E	-	EPS (ttm)	-0.54	Insider Own	21.25%	Shs Outstand	42.19M	Perf Week	15.63%
Market Cap	249.92M	Forward P/E	36.83	EPS next Y	0.16	Insider Trans	-1.04%	Shs Float	34.11M	Perf Month	-16.26%
Income	-21.99M	PEG	-	EPS next Q	-0.06	Inst Own	37.19%	Short Float	18.77%	Perf Quarter	3.41%
Sales	212.45M	P/S	1.18	EPS this Y	88.99%	Inst Trans	-6.15%	Short Ratio	5.86	Perf Half Y	20.21%
Book/sh	-0.13	P/B	-	EPS next Y	368.57%	ROA	-28.84%	Short Interest	6.40M	Perf Year	-27.88%
Cash/sh	0.81	P/C	7.14	EPS next 5Y	-	ROE	-	52W Range	3.99 - 12.88	Perf YTD	16.57%
Dividend Est.	-	P/FCF	15.61	EPS past 5Y	-10.98%	ROI	-206.17%	52W High	-55.20%	Beta	2.20
Dividend TTM	-	Quick Ratio	0.76	Sales past 5Y	88.75%	Gross Margin	83.86%	52W Low	44.61%	ATR (14)	0.68
Dividend Ex-Date	-	Current Ratio	0.81	EPS Y/Y TTM	23.49%	Oper. Margin	-7.35%	RSI (14)	52.13	Volatility	14.34% 12.01%
Employees	232	Debt/Eq	-	Sales Y/Y TTM	39.27%	Profit Margin	-10.35%	Recom	1.25	Target Price	11.94
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	82.98%	Payout	-	Rel Volume	2.53	Prev Close	5.57
Sales Surprise	11.80%	EPS Surprise	61.09%	Sales Q/Q	43.23%	Earnings	Mar 10 AMC	Avg Volume	1.09M	Price	5.77
SMA20	-1.24%	SMA50	2.60%	SMA200	-0.61%	Trades		Volume	2,767,912	Change	3.50%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Initiated	Lake Street	Buy	$12
Dec-04-24	Initiated	Mizuho	Neutral	$7
Aug-23-24	Resumed	B. Riley Securities	Buy	$11
Jun-05-24	Initiated	KeyBanc Capital Markets	Overweight	$12
Nov-30-23	Initiated	Craig Hallum	Buy	$10
Jul-21-23	Initiated	Cantor Fitzgerald	Overweight	$7
Jul-03-23	Initiated	H.C. Wainwright	Buy	$9
Mar-10-22	Initiated	Colliers Securities	Buy	$14
Oct-04-21	Resumed	B. Riley Securities	Buy	$16

Mar-11-25 03:02AM	LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions (GuruFocus.com) +30.56%
Mar-10-25 05:30PM	LifeMD Reports Fourth Quarter 2024 Results (GlobeNewswire) -8.57%
Mar-07-25 07:06AM	LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Mar-06-25 08:00AM	LifeMD Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound (GlobeNewswire)
Mar-05-25 08:00AM	LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
08:05AM	Loading…
Feb-25-25 08:05AM	LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 (GlobeNewswire) -13.11%
Feb-24-25 08:05AM	LifeMD Announces Entry Into the Behavioral Health Market (GlobeNewswire)
Jan-28-25 08:00AM	LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) +6.80%
Jan-07-25 08:30AM	Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND For GLP-1 Users and Those Looking for Help to Keep Weight Off (Business Wire)
Dec-24-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-05-24 08:30AM	Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential Even with Weight Loss Medications (Business Wire) -9.44%
08:00AM	LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution (GlobeNewswire)
Nov-12-24 08:00AM	LifeMD to Participate in Three Investor Conferences During November (GlobeNewswire)
Nov-07-24 04:05PM	LifeMD Reports Third Quarter 2024 Results (GlobeNewswire) +14.04%
Nov-06-24 08:00AM	LifeMD Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency (GlobeNewswire) +13.45%
07:45AM	Loading…
07:45AM	Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result (GuruFocus.com)
Nov-04-24 04:05PM	Medifast Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-24-24 08:26AM	LifeMD launches TestoRx, direct to consumer testosterone replacement therapy (TipRanks)
08:00AM	LifeMD to Report Third Quarter 2024 Financial Results on November 7 (GlobeNewswire)
Oct-23-24 08:00AM	LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering (GlobeNewswire)
Sep-24-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +10.94% -9.15%
Sep-19-24 08:00AM	LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options (GlobeNewswire)
Sep-11-24 02:01PM	Medifast (MED): A Bull Case Theory (Insider Monkey) +6.45%
Aug-26-24 04:05PM	LifeMD to Participate in Three Investor Conferences During September (GlobeNewswire) -9.74%
Aug-07-24 04:05PM	LifeMD Reports Second Quarter 2024 Results (GlobeNewswire) -7.17%
Jul-30-24 08:00AM	LifeMD to Report Second Quarter 2024 Financial Results on August 7 (GlobeNewswire)
Jul-25-24 08:00AM	LifeMD to Participate in Two Investor Conferences During August (GlobeNewswire)
Jul-16-24 07:05AM	3 Overlooked Telehealth Stocks Poised for a Comeback (InvestorPlace)
Jun-25-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
08:00AM	LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management (GlobeNewswire)
08:00AM	Loading…
Jun-10-24 08:00AM	LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit (GlobeNewswire)
May-29-24 08:00AM	LifeMD Set to Join the Russell 3000 Index (GlobeNewswire)
May-09-24 11:46AM	LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript (Insider Monkey) -24.57%
May-08-24 09:58PM	LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance (GlobeNewswire)
May-02-24 08:00AM	LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition (GlobeNewswire) +7.30%
May-01-24 09:40AM	Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 08:00AM	LifeMD Appoints Dr. Calum MacRae to its Board of Directors (GlobeNewswire)
Apr-24-24 08:00AM	LifeMD to Report First Quarter 2024 Financial Results on May 8 (GlobeNewswire)
Apr-23-24 08:00AM	LifeMD to Participate in Upcoming Investor and Industry Conferences During May (GlobeNewswire) +8.90%
Mar-26-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-25-24 08:00AM	LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-24 05:30PM	LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.41%
04:05PM	LifeMD Reports Fourth Quarter 2023 Results (GlobeNewswire)
Feb-26-24 08:00AM	LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 (GlobeNewswire) +5.71%
Feb-15-24 08:00AM	LifeMD to Participate in Upcoming Investor Conferences and Webinar (GlobeNewswire)
Jan-31-24 08:00AM	LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Jan-18-24 08:00AM	LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference (GlobeNewswire)
Jan-08-24 08:00AM	LifeMD Provides 2024 Financial Guidance (GlobeNewswire) +6.97%
Jan-04-24 05:11PM	Why LifeMD's CEO isn't concerned about Eli Lilly's DTC site (Yahoo Finance Video) -32.05%
12:23PM	WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery (Bloomberg)
Dec-26-23 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-13-23 05:22PM	Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its Mind (The Wall Street Journal) -6.42% +6.07%
06:01AM	Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight-Loss Drugs With New Deal (The Wall Street Journal)
06:00AM	LifeMD and Medifast Partner to Offer Transformative Weight Management Solution (GlobeNewswire)
Dec-07-23 08:00AM	LifeMD Executives to Participate in RWJBarnabas Health's Telehealth Symposium (GlobeNewswire)
Dec-05-23 10:25AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE)
Nov-10-23 08:00AM	LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions (GlobeNewswire)
Nov-08-23 04:05PM	LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA (GlobeNewswire)
08:00AM	LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 (GlobeNewswire)
Oct-25-23 08:00AM	LifeMD to Report Third Quarter 2023 Financial Results on November 8 (GlobeNewswire)
Oct-09-23 09:55AM	Maxim Group LLC to Host the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T. (GlobeNewswire)
Oct-03-23 06:00AM	Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy (GlobeNewswire)
Sep-27-23 08:00AM	LifeMD to Participate in Two Investor Conferences in October (GlobeNewswire)
Sep-26-23 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +12.42%
Sep-21-23 06:00AM	LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy (GlobeNewswire)
Aug-30-23 08:00AM	LifeMD to Participate in Two Investor Conferences in September (GlobeNewswire) +5.16%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-09-23 04:05PM	LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance (GlobeNewswire) +19.67%
Aug-02-23 08:00AM	LifeMD to Present at Sidotis Micro-Cap Virtual Conference (GlobeNewswire) -5.39%
Jul-26-23 08:00AM	LifeMD to Report Second Quarter 2023 Financial Results on August 9 (GlobeNewswire) +5.99%
Jul-23-23 05:24AM	TipRanks Perfect 10 List: Analysts Pound the Table on These Top-Rated Stocks (TipRanks)
Jun-27-23 04:30PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +7.07%
06:00AM	LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements (GlobeNewswire)
Jun-20-23 08:00AM	LifeMD Appoints William J. Febbo to its Board of Directors (GlobeNewswire) +5.64%
May-23-23 08:00AM	LifeMD, Inc. to Present at the June 1st Virtual Investor Summit (Newsfile)
May-12-23 07:30AM	LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA (GlobeNewswire)
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-08-23 08:00AM	LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement (GlobeNewswire) +6.98%
May-03-23 08:00AM	LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023 (GlobeNewswire)
Apr-24-23 08:00AM	LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare (GlobeNewswire)
Mar-28-23 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +6.21%
Mar-22-23 04:05PM	LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA Profitability (GlobeNewswire) +19.66%
08:00AM	LifeMD, Inc. Announces Closing of New $40 Million Credit Facility (GlobeNewswire)
Mar-07-23 08:00AM	LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Feb-10-23 08:00AM	LifeMD Appoints Dr. Joan LaRovere to its Board of Directors (GlobeNewswire)
Jan-04-23 08:00AM	LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Companys Rapid Expansion into Virtual Primary Care (GlobeNewswire)
Dec-27-22 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Nov-22-22 08:00AM	LifeMD, Inc. Ranked Number 140 Fastest Growing Company on Deloittes 2022 North America Technology Fast 500 (GlobeNewswire)
Nov-18-22 04:05PM	LifeMD, Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-10-22 04:05PM	LifeMD, Inc. Reports Third Quarter 2022 Results (GlobeNewswire) +19.23%
Oct-26-22 08:00AM	LifeMD, Inc. to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 10, 2022 (GlobeNewswire) +5.45%
Sep-27-22 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Sep-20-22 08:00AM	LifeMD Appoints Bobby Jindal to the Board of Directors (GlobeNewswire)
Sep-14-22 08:00AM	LifeMD Expands Primary Care Platforms Diagnostic Capabilities with New At-Home Screening Kits For Early Warning Signs Of Cancer (GlobeNewswire)
Aug-22-22 08:00AM	LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis (GlobeNewswire)
Aug-16-22 03:00PM	Sidoti's August Micro-Cap Virtual Conference (ACCESSWIRE) -5.21%
Aug-11-22 04:05PM	LifeMD, Inc. Reports Second Quarter 2022 Results (GlobeNewswire) +7.51% -7.94%
Aug-07-22 08:42AM	Investing in LifeMD (NASDAQ:LFMD) three years ago would have delivered you a 340% gain (Simply Wall St.)

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schreiber Justin	Chief Executive Officer	Feb 14 '25	Sale	7.55	50,000	377,620	2,653,715	Feb 21 05:34 PM
Schreiber Justin	Chief Executive Officer	Jan 02 '25	Sale	5.19	25,000	129,668	2,703,715	Jan 06 05:33 PM
Schreiber Justin	Chief Executive Officer	Dec 02 '24	Sale	6.52	25,000	162,925	2,728,715	Dec 04 05:07 PM
Justin Schreiber	CEO	Dec 02 '24	Proposed Sale	6.60	100,000	660,000		Dec 02 05:31 PM
Galluppi Stefan	Chief Innovation Officer	Sep 11 '24	Buy	4.93	3,000	14,790	45,449	Sep 12 02:10 PM

Dollar change +0.0159
Percentage change 2.52	%

TOI Oncology Institute Inc daily Stock Chart

Peers: AMGN BMY PFE MRK LLY AZN GILD REGN VRTX BIIB

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-0.77	Insider Own	51.29%	Shs Outstand	75.56M	Perf Week	-1.76%
Market Cap	48.88M	Forward P/E	-	EPS next Y	-	Insider Trans	0.78%	Shs Float	36.80M	Perf Month	-35.31%
Income	-57.49M	PEG	-	EPS next Q	-	Inst Own	15.03%	Short Float	2.90%	Perf Quarter	208.05%
Sales	378.93M	P/S	0.13	EPS this Y	-	Inst Trans	-28.20%	Short Ratio	1.31	Perf Half Y	117.81%
Book/sh	0.20	P/B	3.16	EPS next Y	-	ROA	-28.92%	Short Interest	1.07M	Perf Year	-61.49%
Cash/sh	0.63	P/C	1.03	EPS next 5Y	-	ROE	-131.66%	52W Range	0.13 - 1.94	Perf YTD	109.35%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-879.48%	ROI	-43.66%	52W High	-66.65%	Beta	0.58
Dividend TTM	-	Quick Ratio	2.27	Sales past 5Y	15.26%	Gross Margin	12.56%	52W Low	416.28%	ATR (14)	0.12
Dividend Ex-Date	-	Current Ratio	2.49	EPS Y/Y TTM	5.08%	Oper. Margin	-16.75%	RSI (14)	42.65	Volatility	14.99% 15.60%
Employees	800	Debt/Eq	7.94	Sales Y/Y TTM	22.29%	Profit Margin	-15.17%	Recom	1.00	Target Price	2.00
Option/Short	No / Yes	LT Debt/Eq	7.51	EPS Q/Q	9.84%	Payout	-	Rel Volume	0.11	Prev Close	0.63
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	21.78%	Earnings	Mar 25 AMC	Avg Volume	817.98K	Price	0.65
SMA20	-20.01%	SMA50	-6.47%	SMA200	46.57%	Trades		Volume	91,004	Change	2.52%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-24	Resumed	Jefferies	Buy	$2.50
Sep-14-22	Initiated	Guggenheim	Buy	$7
Aug-15-22	Initiated	Jefferies	Buy	$10

Mar-04-25 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-25 08:00AM	The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown (GlobeNewswire) +19.66%
Dec-18-24 04:05PM	Florida Blue enhances cancer care for thousands of members (GlobeNewswire) +11.12%
Nov-13-24 04:05PM	The Oncology Institute Reports Third Quarter 2024 Financial Results (GlobeNewswire) -9.03% -10.84%
Nov-11-24 08:00AM	The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California (GlobeNewswire)
07:09PM	Loading…
Nov-04-24 07:09PM	The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -6.64%
Oct-23-24 08:00AM	The Oncology Institute Joins Lantern's Cancer Care Network of Excellence (GlobeNewswire)
Oct-14-24 08:00AM	The American Journal of Managed Care and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care (GlobeNewswire)
Sep-30-24 08:00AM	The Oncology Institute of Hope & Innovation Launches Oregon Market (GlobeNewswire) +5.59%
Sep-23-24 08:00AM	The Oncology Institute Announces CFO Transition (GlobeNewswire)
Aug-13-24 04:05PM	The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance (GlobeNewswire) +13.40% -18.18%
Jul-23-24 08:00AM	The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-29-24 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-22-24 08:00AM	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference (GlobeNewswire)
May-15-24 03:14AM	The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -24.00%
06:05PM	Loading…
May-14-24 06:05PM	The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance (GlobeNewswire)
May-07-24 04:05PM	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit (GlobeNewswire) -6.08%
Apr-23-24 08:00AM	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-08-24 08:00AM	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute (GlobeNewswire) +6.00%
Apr-04-24 08:00AM	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California (GlobeNewswire)
Apr-01-24 01:35PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:52PM	TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +8.88% -14.13%
05:34PM	The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 (GlobeNewswire)
Mar-21-24 09:35AM	Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround (Zacks)
Mar-14-24 08:09AM	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership (GlobeNewswire) +5.62%
Mar-06-24 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-27-24 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 08:00AM	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model (GlobeNewswire)
08:00AM	Loading…
Jan-25-24 08:00AM	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio (GlobeNewswire)
Dec-04-23 08:00AM	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California (GlobeNewswire)
Nov-16-23 05:04AM	Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) (GuruFocus.com) -7.21%
Nov-11-23 12:43PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:50PM	The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens (GuruFocus.com) +5.75% +27.72%
04:05PM	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Oct-18-23 08:03AM	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-11-23 04:05PM	The Oncology Institute Names Jeremy Castle as Chief Operations Officer (GlobeNewswire)
Sep-26-23 04:05PM	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit (GlobeNewswire)
Sep-18-23 08:00AM	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-09-23 08:10AM	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology (GlobeNewswire)
Aug-08-23 04:40PM	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Aug-02-23 06:16AM	Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago (Simply Wall St.) -5.71%
Jul-31-23 08:00AM	The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations (GlobeNewswire)
Jul-18-23 08:00AM	The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jun-12-23 06:00AM	The Oncology Institute Announces Leadership Transition (GlobeNewswire) -9.02%
Jun-09-23 08:00AM	The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research (GlobeNewswire) -5.31%
Jun-07-23 08:00AM	The Oncology Institute to Open Project Southland (GlobeNewswire) +17.07%
May-31-23 08:01AM	The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting (GlobeNewswire)
08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-10-23 04:05PM	The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
May-04-23 11:47AM	The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education (PR Newswire)
May-02-23 08:00AM	TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer (GlobeNewswire) -6.51%
Apr-19-23 08:00AM	The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Mar-16-23 08:08PM	CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -12.41% -17.07%
Mar-09-23 04:20PM	The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -11.35% -19.60%
Feb-28-23 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 08:00AM	The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Dec-19-22 08:00AM	The Oncology Institute Expands Into Chino, CA (GlobeNewswire)
Dec-15-22 08:00AM	The Oncology Institute Rebrands Clinical Trials Division (GlobeNewswire) -7.26%
Nov-22-22 08:00AM	The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa (GlobeNewswire) +5.70%
Nov-09-22 04:05PM	The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance (GlobeNewswire) -5.16%
Nov-01-22 08:00AM	The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference (GlobeNewswire) -8.59%
Oct-19-22 08:00AM	The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-17-22 04:05PM	The Oncology Institute Executives to Speak at Key Industry Conferences in Q4 (GlobeNewswire) +6.08%
Oct-11-22 08:00AM	The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials (GlobeNewswire) +5.37%
Oct-06-22 08:00AM	The Oncology Institute Expands into South Florida (GlobeNewswire)
Sep-29-22 08:00AM	The Oncology Institute Enrolls Nations First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib (GlobeNewswire)
Sep-22-22 04:05PM	The Oncology Institute Appoints Two New Board Members (GlobeNewswire)
Sep-15-22 08:00AM	The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium (GlobeNewswire) -7.62%
Sep-12-22 08:00AM	The Oncology Institute Becomes Certified as a Patient Safety Organization (GlobeNewswire)
Aug-22-22 08:00AM	The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms (GlobeNewswire)
Aug-16-22 08:00AM	The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day (GlobeNewswire) +9.21%
Aug-09-22 04:06PM	The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance (GlobeNewswire) +9.95%
04:05PM	The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets (GlobeNewswire)
Jul-26-22 08:00AM	The Oncology Institute Continues its Nevada Expansion (GlobeNewswire)
Jul-19-22 08:00AM	The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-07-22 04:05PM	The Oncology Institute Continues Southern California Expansion (GlobeNewswire) -5.51%
Jun-27-22 08:00AM	The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals (GlobeNewswire) -6.55%
Jun-21-22 08:00AM	The Oncology Institute to Participate at the Cowen Virtual FutureHealth Conference (GlobeNewswire)
Jun-07-22 04:05PM	The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes (GlobeNewswire) -8.96%
Jun-02-22 04:05PM	The Oncology Institute Announces Opening of Austins Newest Innovative Cancer Clinics (GlobeNewswire)
May-17-22 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire) +6.37% +15.70%
May-11-22 06:00AM	The Oncology Institute Reports First Quarter 2022 Financial Results and Confirms Full Year 2022 Guidance (GlobeNewswire) -14.72%
May-09-22 09:59AM	Investors in Oncology Institute (NASDAQ:TOI) from a year ago are still down 12%, even after 12% gain this past week (Simply Wall St.) -21.23%
May-02-22 08:00AM	The Oncology Institute of Hope & Innovation Adds Fresno Practice to Network (GlobeNewswire) +15.78%
Apr-20-22 08:00AM	The Oncology Institute Announces First Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-07-22 04:05PM	The Oncology Institute Reaches $9.5M Total Saved to Medicare While Exceeding Quality Benchmarks (GlobeNewswire) -9.30%
Apr-04-22 06:01AM	The Oncology Institute Names Mihir Shah as Chief Financial Officer (GlobeNewswire) +11.76%
Mar-29-22 09:39PM	Constellation Software Inc. and Topicus.com Inc. Announce Annual Meetings (GlobeNewswire)
Mar-22-22 08:08AM	Topicus.com's subsidiary TSS Europe B.V. (TSS) submits public tender offer to acquire Sygnity S.A. (GlobeNewswire)
Mar-18-22 07:45AM	The Returns At Topicus.com (CVE:TOI) Aren't Growing (Simply Wall St.)
Mar-16-22 04:05PM	The Oncology Institute Adds New Culver City Clinic and Expands Riverside Location (GlobeNewswire) -5.26%
07:29AM	The Oncology Institute, Inc. (NASDAQ:TOI) insiders are still down US$1.2k after purchasing last year, recent gain helped regain some losses (Simply Wall St.)
Mar-10-22 04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Strong Growth Outlook for 2022 (GlobeNewswire) -14.56% +10.34%
Mar-08-22 04:05PM	The Oncology Institute to Participate at the Jefferies Value-Based Healthcare Summit (GlobeNewswire) +10.75%
Mar-07-22 04:05PM	The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller (GlobeNewswire) -17.02%
Mar-03-22 01:50PM	UPDATE - The Oncology Institute Enters Into Value-Based Agreement with MaxHealth (GlobeNewswire) +15.47%
08:00AM	The Oncology Institute Enters Into Value-Based Agreement with MaxHeath (GlobeNewswire)
Feb-17-22 08:30AM	The Oncology Institute Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference Call (GlobeNewswire)

The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hively Brad	Director	Nov 26 '24	Buy	0.17	250,000	42,500	616,753	Dec 02 04:04 PM
Hively Brad	Director	Dec 02 '24	Buy	0.15	50,000	7,500	666,753	Dec 02 04:04 PM

AIRS Airsculpt Technologies Inc daily Stock Chart

Peers: LGVN DERM HROW VRCA PMVP RCEL CARA DBVT BKD CDTX

| Held by: VTI IWM VXF IWO VTWO SCHA ONEQ IWC VTWG AVSC

Index	RUT	P/E	-	EPS (ttm)	-0.14	Insider Own	78.13%	Shs Outstand	57.81M	Perf Week	-22.14%
Market Cap	181.17M	Forward P/E	17.66	EPS next Y	0.18	Insider Trans	-0.36%	Shs Float	12.66M	Perf Month	-42.57%
Income	-7.79M	PEG	-	EPS next Q	0.01	Inst Own	23.26%	Short Float	24.35%	Perf Quarter	-51.70%
Sales	188.78M	P/S	0.96	EPS this Y	-76.99%	Inst Trans	5.02%	Short Ratio	14.93	Perf Half Y	-15.63%
Book/sh	1.43	P/B	2.19	EPS next Y	175.16%	ROA	-3.78%	Short Interest	3.08M	Perf Year	-48.26%
Cash/sh	0.10	P/C	30.35	EPS next 5Y	-1.51%	ROE	-9.35%	52W Range	2.91 - 9.20	Perf YTD	-39.69%
Dividend Est.	-	P/FCF	150.97	EPS past 5Y	-18.66%	ROI	-4.45%	52W High	-65.98%	Beta	1.87
Dividend TTM	-	Quick Ratio	0.51	Sales past 5Y	51.82%	Gross Margin	55.52%	52W Low	7.56%	ATR (14)	0.45
Dividend Ex-Date	Aug 25, 2022	Current Ratio	0.51	EPS Y/Y TTM	-6.86%	Oper. Margin	5.82%	RSI (14)	26.49	Volatility	13.29% 10.22%
Employees	346	Debt/Eq	1.24	Sales Y/Y TTM	-0.12%	Profit Margin	-4.13%	Recom	2.60	Target Price	6.83
Option/Short	Yes / Yes	LT Debt/Eq	1.12	EPS Q/Q	-256.46%	Payout	-	Rel Volume	0.80	Prev Close	2.94
Sales Surprise	1.95%	EPS Surprise	-614.29%	Sales Q/Q	-9.07%	Earnings	Mar 14 BMO	Avg Volume	206.50K	Price	3.13
SMA20	-31.86%	SMA50	-37.67%	SMA200	-37.89%	Trades		Volume	164,509	Change	6.46%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Neutral
May-14-24	Downgrade	Leerink Partners	Outperform → Market Perform	$8.25 → $5
Nov-11-22	Downgrade	Piper Sandler	Overweight → Neutral	$4
Jun-16-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $8.50
Nov-23-21	Initiated	SVB Leerink	Outperform	$26
Nov-23-21	Initiated	Raymond James	Outperform	$18
Nov-23-21	Initiated	Piper Sandler	Overweight	$22
Nov-23-21	Initiated	Morgan Stanley	Overweight	$17

Mar-11-25 09:15AM	Unveiling AirSculpt Technologies (AIRS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks) -11.45%
Mar-06-25 06:45AM	AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-13-25 06:45AM	AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 (GlobeNewswire) -19.90%
Jan-07-25 06:45AM	AirSculpt Technologies Announces Participation in the ICR Conference 2025 (GlobeNewswire)
Dec-17-24 06:45AM	AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer (GlobeNewswire) +5.18%
10:42PM	Loading…
Dec-10-24 10:42PM	Why Is AirSculpt Technologies Inc. (AIRS) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey) -5.67%
Dec-02-24 01:22PM	AirSculpt Technologies, Inc. Announces Opening of Its New White Plains, NY Center (PR Newswire)
Nov-09-24 02:04AM	AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
01:34AM	Q3 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-24 09:30AM	AirSculpt Technologies (AIRS) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +20.72%
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results (GlobeNewswire)
Nov-07-24 07:09AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings (GuruFocus.com) -6.14%
Nov-05-24 11:17AM	AirSculpt Technologies (AIRS) Moves 14.2% Higher: Will This Strength Last? (Zacks)
Oct-24-24 06:30AM	AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results (GlobeNewswire) +5.26%
08:05AM	Loading…
Oct-15-24 08:05AM	AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Oct-01-24 12:48PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI (PR Newswire) -6.31%
Sep-24-24 01:30PM	AirSculpt Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand (PR Newswire) +7.34%
Sep-19-24 08:32AM	Do Options Traders Know Something About AirSculpt Technologies (AIRS) Stock We Don't? (Zacks) +6.77%
Aug-23-24 08:30AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks)
Aug-19-24 12:00PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Columbus, OH (PR Newswire)
Aug-10-24 08:18AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies (AIRS) Q2 Earnings (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:33AM	AirSculpt Technologies, Inc. (AIRS): The Best Cosmetic Surgery and Aesthetics Stocks To Buy? (Insider Monkey)
06:10AM	AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results (GlobeNewswire)
06:00AM	AirSculpt Technologies Announces Leadership Changes (GlobeNewswire)
Aug-07-24 09:15AM	Ahead of AirSculpt Technologies (AIRS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
11:57AM	Loading…
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-17-24 06:00AM	3 Short-Squeeze Stocks to Buy Before July for 20% Returns (InvestorPlace)
May-31-24 09:36AM	Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't? (Zacks)
May-24-24 09:55AM	Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher (Zacks)
09:35AM	Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround (Zacks)
May-13-24 03:06AM	AirSculpt Technologies Inc (AIRS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-11-24 10:19AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:32PM	AirSculpt Technologies Inc (AIRS) Exceeds First Quarter Revenue Estimates with Strong Performance (GuruFocus.com) -12.06%
01:48PM	AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall (MT Newswires)
10:53AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics (Zacks)
07:15AM	AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports for First Quarter Earnings (GlobeNewswire)
May-08-24 09:15AM	Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-30-24 07:00AM	AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-29-24 08:30AM	AirSculpt Relocates and Expands to New Location to Meet Market Demand (PR Newswire)
Mar-19-24 08:30AM	AirSculpt Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client (PR Newswire)
Mar-18-24 07:00AM	Bear of the Day: AirSculpt (AIRS) (Zacks)
Mar-12-24 03:59PM	Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics (InvestorPlace)
Mar-10-24 10:18AM	10 Botox Alternatives for Smoothing Wrinkles and Anti-Aging Treatment (Insider Monkey)
Mar-07-24 07:00AM	AirSculpt Technologies Announces Participation at BofA Securities Consumer and Retail Conference (GlobeNewswire)
Mar-04-24 08:30AM	AirSculpt Technologies, Inc. Expands Its Scottsdale Location (PR Newswire) -5.10%
Feb-29-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm (GlobeNewswire)
Feb-28-24 08:52AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 09:53PM	Q4 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Q4 Earnings and Revenues Miss Estimates (Zacks)
06:36AM	AirSculpt Technologies Inc (AIRS) Reports Strong Revenue and EBITDA Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:00AM	AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023 (GlobeNewswire)
Feb-26-24 07:28PM	AirSculpt Technologies, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) +7.86%
09:16AM	What Analyst Projections for Key Metrics Reveal About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
Feb-23-24 09:15AM	Airsculpt shares slide after Fuzzy Panda takes short position (Reuters) -5.65%
Jan-31-24 07:00AM	AirSculpt Technologies Announces Fourth Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-25-24 12:00PM	What Makes AirSculpt Technologies, Inc. (AIRS) a New Strong Buy Stock (Zacks)
Jan-01-24 09:40AM	Is AirSculpt Technologies (AIRS) Outperforming Other Business Services Stocks This Year? (Zacks)
Dec-19-23 08:34AM	Are Options Traders Betting on a Big Move in AirSculpt (AIRS) Stock? (Zacks)
Nov-11-23 08:42AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 09:54PM	Q3 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) -10.04%
Nov-09-23 07:00PM	AirSculpt Technologies, Inc. (AIRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -9.06%
04:01PM	AirSculpt Technologies Announces Third Quarter 2023 Results and Reaffirms 2023 Guidance (GlobeNewswire)
Nov-08-23 12:28PM	AirSculpt (AIRS) to Report Q3 Earnings: What's in the Cards? (Zacks)
Nov-03-23 10:00AM	AirSculpt Technologies, Inc. (AIRS) Earnings Expected to Grow: Should You Buy? (Zacks) +9.36%
Nov-01-23 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Oct-27-23 07:00AM	AirSculpt Technologies Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-17-23 09:30AM	AirSculpt Technologies, Inc. Announces Partnership with Singer and TV Personality, Joey Fatone to Transform his Body with AirSculpt (GlobeNewswire)
Oct-16-23 09:40AM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks) +5.52%
Oct-05-23 07:00AM	AirSculpt Technologies Announces Strong Preliminary Third Quarter 2023 Revenue Results and Updates 2023 Revenue and Adjusted EBITDA Guidance (GlobeNewswire)
Sep-25-23 09:40AM	Is AirSculpt Technologies (AIRS) Outperforming Other Business Services Stocks This Year? (Zacks)
Sep-18-23 08:30AM	AirSculpt® Technologies, Inc. Announces Opening of Its Newest Location in Raleigh (GlobeNewswire)
Sep-07-23 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
08:30AM	AirSculpt® Technologies, Inc. Introduces AirSculpt Lift, an Alternative to Synthetic Dermal Fillers (GlobeNewswire)
Sep-03-23 05:29AM	12 Cheapest and Best Countries for Plastic Surgery (Insider Monkey)
Aug-27-23 01:54PM	10 Best Cosmetic Surgery and Aesthetics Stocks to Buy (Insider Monkey)
Aug-23-23 09:49AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks) +6.79%
Aug-22-23 05:20PM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Aug-12-23 08:14AM	Here's What's Concerning About AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital (Simply Wall St.)
Aug-11-23 09:49PM	Q2 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	AirSculpt Technologies, Inc. (AIRS) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings Lag Estimates (Zacks)
06:00AM	AirSculpt Technologies Announces Second Quarter 2023 Results and Reaffirms 2023 Guidance (GlobeNewswire)
Aug-04-23 08:30AM	AirSculpt® Technologies, Inc. Hosts IG Live With AirSculpt Celebrity Client, Jenny McCarthy and Dr. Aaron Rollins (GlobeNewswire)
Jul-28-23 07:00AM	AirSculpt Technologies Announces Second Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-24-23 07:00AM	AirSculpt® Technologies, Inc. Announces Opening of Its Newest Location In San Jose (GlobeNewswire)
Jul-19-23 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Jul-11-23 08:25AM	5 Small-Cap Stocks That Soared in 1H & Have More Upside (Zacks) +10.12%
06:00AM	AirSculpt Technologies Announces Strong Preliminary Second Quarter 2023 Revenue, Reaffirms 2023 Revenue Guidance and Updates 2023 Adjusted EBITDA Guidance (GlobeNewswire)
Jun-14-23 09:40AM	Are Business Services Stocks Lagging AirSculpt Technologies (AIRS) This Year? (Zacks)
Jun-07-23 08:30AM	AirSculpt® Technologies, Inc. Announces Actress and TV Personality Jenny McCarthy as Latest AirSculpt Client (GlobeNewswire)
May-16-23 06:04AM	Earnings Update: Here's Why Analysts Just Lifted Their AirSculpt Technologies, Inc. (NASDAQ:AIRS) Price Target To US$7.19 (Simply Wall St.)
May-12-23 10:50PM	Q1 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +37.42%

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rollins Aaron	Executive Chairman	Nov 15 '24	Sale	6.54	49,019	320,815	14,986,689	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 14 '24	Sale	7.17	44,756	320,677	15,035,708	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 13 '24	Sale	7.53	15,438	116,231	15,080,464	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 15 '24	Sale	6.54	24,510	160,411	582,052	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 14 '24	Sale	7.17	22,378	160,338	606,562	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 13 '24	Sale	7.53	7,719	58,116	628,940	Nov 15 09:44 PM
Dennis Dean	Interim CEO and CFO	Nov 15 '24	Proposed Sale	6.51	2,561	16,672		Nov 15 09:33 PM
Dennis Dean	Interim CEO and CFO	Nov 12 '24	Proposed Sale	7.19	52,046	374,217		Nov 13 02:03 PM
Todd Magazine	Former Officer and Director	Sep 16 '24	Proposed Sale	4.26	76,693	326,932		Oct 25 07:22 PM

SBC SBC Medical Group Holdings Inc daily Stock Chart

Index	-	P/E	-	EPS (ttm)	-0.13	Insider Own	98.49%	Shs Outstand	103.02M	Perf Week	-28.26%
Market Cap	339.97M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.56M	Perf Month	-35.67%
Income	1.87M	PEG	-	EPS next Q	0.17	Inst Own	0.03%	Short Float	1.74%	Perf Quarter	-46.52%
Sales	53.08M	P/S	6.40	EPS this Y	19.33%	Inst Trans	90.20%	Short Ratio	0.71	Perf Half Y	-67.00%
Book/sh	1.99	P/B	1.66	EPS next Y	-	ROA	1.17%	Short Interest	0.03M	Perf Year	-69.53%
Cash/sh	1.33	P/C	2.47	EPS next 5Y	-	ROE	1.70%	52W Range	2.62 - 36.52	Perf YTD	-40.65%
Dividend Est.	-	P/FCF	8.79	EPS past 5Y	-	ROI	0.85%	52W High	-90.96%	Beta	0.84
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	0.00%	Gross Margin	80.16%	52W Low	25.95%	ATR (14)	0.42
Dividend Ex-Date	Jan 06, 2011	Current Ratio	2.79	EPS Y/Y TTM	-260.00%	Oper. Margin	23.06%	RSI (14)	26.64	Volatility	23.31% 12.05%
Employees	2	Debt/Eq	0.14	Sales Y/Y TTM	-	Profit Margin	3.52%	Recom	-	Target Price	10.00
Option/Short	No / Yes	LT Debt/Eq	0.07	EPS Q/Q	256.84%	Payout	0.00%	Rel Volume	0.65	Prev Close	3.30
Sales Surprise	0.29%	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Feb 26	Avg Volume	38.03K	Price	3.30
SMA20	-25.11%	SMA50	-32.36%	SMA200	-62.46%	Trades		Volume	24,604	Change	0.00%

Feb-12-25 07:00AM	SBC Medical Group Holdings Announces its Purchase of Bitcoin (Business Wire)
Jan-21-25 09:00AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-20-25 07:00AM	SBC Medical Launches Translation App Specialized Medical Aesthetics and Strengthens 'Inbound-Focused Clinics' Initiative (Business Wire)
Dec-21-24 07:10AM	SBC Medical Group to sell two subsidiaries to CEO Yoshiyuki Aikawa (TipRanks)
Dec-20-24 07:00AM	SBC Medical Group Co., Ltd. Sells Two Subsidiaries (Business Wire)
07:00AM	Loading…
Nov-19-24 07:00AM	SBC Medical Launches SBC Wellness, a New Solution to Help Companies Deliver Additional Health Benefits and Enhance Employee Wellbeing (Business Wire)
Nov-18-24 07:00AM	SBC Medical Group Holdings Announces Definitive Agreement to Acquire, Aesthetic Healthcare Holdings Pte. Ltd, a Multi-Unit Owner of Aesthetic Treatment Clinics in Singapore (Business Wire)
Nov-13-24 04:59PM	SBC Medical Group Holdings Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-07-24 08:00AM	Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance (GlobeNewswire)
07:00AM	SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance (Business Wire)
Sep-17-24 07:19PM	SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq (Business Wire) -30.36%
Jan-02-24 05:05PM	Horizon Aircraft Announces Board of Directors for Post-Merger Public Company (GlobeNewswire)

SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company was founded on January 20, 2023 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ZUU Co. Ltd.	10% Owner	Aug 22 '24	Buy	10.51	8,399	88,310	1,423,718	Aug 23 05:33 PM
ZUU Co. Ltd.	10% Owner	Aug 01 '24	Buy	12.82	2,487	31,887	1,495,074	Aug 02 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 31 '24	Buy	12.50	12	150	1,492,587	Aug 02 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 24 '24	Buy	13.00	15,509	201,617	1,492,575	Jul 26 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 17 '24	Buy	13.00	5,404	70,252	1,477,064	Jul 19 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 19 '24	Buy	13.00	2	26	1,477,066	Jul 19 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 15 '24	Buy	13.00	4,342	56,446	1,471,660	Jul 16 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 12 '24	Buy	13.00	203	2,639	1,467,318	Jul 16 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 11 '24	Buy	13.00	6,297	81,861	1,467,115	Jul 11 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 10 '24	Buy	13.00	12	156	1,460,818	Jul 11 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 09 '24	Buy	13.00	5	65	1,460,806	Jul 11 09:00 PM
ZUU Co. Ltd.	10% Owner	Jul 02 '24	Buy	13.00	30	390	1,460,801	Jul 05 09:00 PM
ZUU Co. Ltd.	10% Owner	Jun 27 '24	Buy	13.00	2	26	1,460,771	Jul 01 09:01 PM
ZUU Co. Ltd.	10% Owner	Jun 06 '24	Buy	13.00	1,500	19,500	1,460,669	Jun 10 09:00 PM
ZUU Co. Ltd.	10% Owner	Jun 10 '24	Buy	13.00	100	1,300	1,460,769	Jun 10 09:00 PM
ZUU Co. Ltd.	10% Owner	May 31 '24	Buy	13.00	6	78	1,459,169	Jun 04 09:00 PM
ZUU Co. Ltd.	10% Owner	May 23 '24	Buy	13.00	789	10,257	1,459,163	May 28 09:00 PM
ZUU Co. Ltd.	10% Owner	May 16 '24	Buy	13.00	1	13	1,458,374	May 20 09:00 PM
ZUU Co. Ltd.	10% Owner	May 13 '24	Buy	13.00	190	2,470	1,458,225	May 15 09:00 PM
ZUU Co. Ltd.	10% Owner	May 14 '24	Buy	12.99	140	1,819	1,458,365	May 15 09:00 PM
ZUU Co. Ltd.	10% Owner	May 15 '24	Buy	13.00	8	104	1,458,373	May 15 09:00 PM
ZUU Co. Ltd.	10% Owner	May 10 '24	Buy	13.00	312	4,056	1,458,035	May 10 08:15 PM
ZUU Co. Ltd.	10% Owner	May 08 '24	Buy	13.00	1	13	1,457,723	May 10 08:15 PM
ZUU Co. Ltd.	10% Owner	Apr 30 '24	Buy	13.00	47	611	1,457,722	May 02 09:03 PM
ZUU Co. Ltd.	10% Owner	Apr 23 '24	Buy	12.97	2,615	33,911	1,457,675	Apr 25 09:00 PM
ZUU Co. Ltd.	10% Owner	Apr 11 '24	Buy	12.80	4	51	1,455,060	Apr 11 09:00 PM
ZUU Co. Ltd.	10% Owner	Apr 09 '24	Buy	12.80	1	13	1,455,056	Apr 11 09:00 PM
ZUU Co. Ltd.	10% Owner	Apr 05 '24	Buy	12.80	2	26	1,455,055	Apr 08 09:48 PM
ZUU Co. Ltd.	10% Owner	Apr 04 '24	Buy	12.80	2	26	1,455,053	Apr 08 09:48 PM
ZUU Co. Ltd.	10% Owner	Apr 01 '24	Buy	12.80	19,236	246,221	1,455,047	Apr 03 08:00 PM
ZUU Co. Ltd.	10% Owner	Apr 02 '24	Buy	12.80	4	51	1,455,051	Apr 03 08:00 PM
ZUU Co. Ltd.	10% Owner	Mar 27 '24	Buy	12.50	18	225	1,435,810	Mar 28 09:05 PM
ZUU Co. Ltd.	10% Owner	Mar 28 '24	Buy	12.50	1	12	1,435,811	Mar 28 09:05 PM
ZUU Co. Ltd.	10% Owner	Mar 22 '24	Buy	12.50	917	11,462	1,435,743	Mar 26 09:36 PM
ZUU Co. Ltd.	10% Owner	Mar 26 '24	Buy	12.50	46	575	1,435,792	Mar 26 09:36 PM
ZUU Co. Ltd.	10% Owner	Mar 25 '24	Buy	12.50	3	38	1,435,746	Mar 26 09:36 PM
ZUU Co. Ltd.	10% Owner	Mar 19 '24	Buy	12.50	31,535	394,188	1,431,540	Mar 21 07:19 PM
ZUU Co. Ltd.	10% Owner	Mar 21 '24	Buy	12.50	1,734	21,675	1,434,826	Mar 21 07:19 PM
ZUU Co. Ltd.	10% Owner	Mar 20 '24	Buy	12.50	1,552	19,400	1,433,092	Mar 21 07:19 PM

TDOC

Teladoc Health Inc

HIMS

Hims & Hers Health Inc

LFMD

LifeMD Inc

TOI

Oncology Institute Inc

AIRS

Airsculpt Technologies Inc

SBC

SBC Medical Group Holdings Inc

Upgrade your FINVIZ experience